Population structure of Escherichia coli causing bacteraemia in the UK and Ireland between 2001 and 2010

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 8, 2016, Pages 2139-2142

  Day, M J ^a   Doumith, M ^a   Abernethy, J ^a   Hope, R ^a   Reynolds, R ^b   Wain, J ^c   Livermore, D M ^a,c   Woodford, N ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; BETA LACTAMASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHILD; CLONAL EVOLUTION; ENGLAND; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFANT; IRELAND; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NEWBORN; NONHUMAN; NORTHERN IRELAND; PHYLOGENY; POPULATION STRUCTURE; SEX; WALES; CLASSIFICATION; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; PRESCHOOL CHILD; PREVALENCE; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; BACTEREMIA; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; IRELAND; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PREVALENCE; UNITED KINGDOM; YOUNG ADULT;

EID: 84982230797     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw145     Document Type: Article

References (20)

1. PHE. Escherichia coli Bacteraemia, Voluntary Surveillance. https://www. gov.uk/government/uploads/system/uploads/attachment_data/file/ 339992/Ecoli_bacteraemia_in_Eng_Wales_and_NI_2009_to_2013.pdf.
2. PHE. Quarterly Counts of E. coli Bacteraemias by Clinical Commissioning Group. https://www.gov.uk/government/statistics/escherichia-coli-e-colibacteraemia- annual-data.
3. Gransden WR, Eykyn SJ, Phillips I et al. Bacteremia due to Escherichia coli: a study of 861 episodes. Clin Infect Dis 1990; 12: 1008-18.
4. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spectrum β-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J Infect 2007; 55: 254-9.
5. Reynolds R, Hope R, Williams L. Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes. J Antimicrob Chemother 2008; 62(Suppl 2): ii15-28.
6. BSAC Resistance Surveillance Project. http://www.bsacsurv.org/.
7. Andrews JM. Determination of Minimum Inhibitory Concentration. http:// bsac.org.uk/wp-content/uploads/2012/02/Chapter-2-Determination-of- MICs-2006updated.pdf.
8. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-5.
9. Doumith M, Day MJ, Hope R et al. Improved multiplex PCR strategy for rapid assignment of the four major Escherichia coli phylogenetic groups. J Clin Microbiol 2012; 50: 3108-10.
10. Wirth T, Falush D, Lan R et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-51.
11. Warwick MLST Database. http://mlst.warwick.ac.uk/mlst/dbs/Ecoli.
12. Livermore DM, Hope R, Reynolds R et al. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 2013; 68: 2667-74.
13. Livermore DM, Hope R, Brick G. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008; 62(Suppl 2): ii41-54.
14. Gibreel TM, Dodgson AR, Cheesbrough J et al. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 2012; 67: 346-56.
15. Johnson JR, Nicolas-Chanoine MH, DebRoy C et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012; 18: 598-607.
16. Horner C, Fawley W, Morris K et al. Escherichia coli bacteraemia: 2 years of prospective regional surveillance (2010-12). J Antimicrob Chemother 2014; 69: 91-100.
17. Lau SH, Reddy S, Cheesbrough J et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008; 46: 1076-80.
18. Doumith M, Day M, Ciesielczuk H et al. Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections. J Clin Microbiol 2015; 53: 160-6.
19. Blanco J, Mora A, Mamani R et al. National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. J Antimicrob Chemother 2011; 66: 2011-21.
20. Alghoribi MF, Gibreel TM, Dodgson AR et al. Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli. PLoS One 2014; 9: e101547.